ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DBTX Decibel Therapeutics Inc

4.91
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 4.91
Ask Price 5.19
News -
Day High

Low
2.41

52 Week Range

High
5.26

Day Low
Company Name Stock Ticker Symbol Market Type
Decibel Therapeutics Inc DBTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 4.91 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.91 4.91
Trades Volume Avg Volume 52 Week Range
0 0 - 2.41 - 5.26
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 4.91 USD

Decibel Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 123.37M - - - -773.69
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Decibel Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DBTX Message Board. Create One! See More Posts on DBTX Message Board See More Message Board Posts

Historical DBTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year2.795.262.414.80130,8062.1275.99%
3 Years11.5111.971.614.91102,984-6.60-57.34%
5 Years21.2024.351.616.20110,532-16.29-76.84%

Decibel Therapeutics Description

Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. Its lead gene therapy product candidate is DB-OTO which provides hearing to individuals born with profound hearing loss due to an OTOF deficiency. The firm's pipeline products comprise DB-ATO, AAV.103, AAV.104, AAV.201, DB-020, and Cochlear Hair Cell Regeneration.

Your Recent History

Delayed Upgrade Clock